Trisk Bio and NanoMosaic Announce Partnership for Advanced AAV Analytics
Trisk Bio Ltd, a UK-based AAV contract development and manufacturing organisation (CDMO), and NanoMosaic, Inc., a leader in advanced analytical technologies for cell and gene therapy, today announced a partnership to embed the Tessie analytics platform across Trisk's AAV process development, quality control, and release testing workflows.
